Insider Trading History of Jackson Scott Thomas

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Jackson Scott Thomas since 2013. This trader's CIK number is 1566617. At the time of last reporting, Jackson Scott Thomas was the Director of Macrogenics Inc. (stock ticker symbol MGNX). Also see all insider trading activities at Macrogenics Inc.

Note that in the past Jackson Scott Thomas also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Celator Pharmaceuticals Inc (CPXX) by Jackson Scott Thomas

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 CPXX 0 $0 0 $0 251,475 $748,138
2015 CPXX 14,450 $25,143 0 $0 0 $0
2014 CPXX 10,000 $22,000 0 $0 0 $0
2013 CPXX 3,000 $10,491 0 $0 0 $0

Yearly summary of insider trading at Macrogenics Inc (MGNX) by Jackson Scott Thomas

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 MGNX 0 $0 0 $0 6,500 $0
2024 MGNX 0 $0 0 $0 4,500 $0


Insider trading activities at 2 companies by Jackson Scott Thomas:

1. Celator Pharmaceuticals Inc (CPXX)

2. Macrogenics Inc (MGNX)

Table 1. Insider trading of Celator Pharmaceuticals Inc (CPXX) by Jackson Scott Thomas

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-07-07 CPXX Option Ex 251,475 2.98 748,138
2015-10-06 CPXX Buy 14,450 1.74 25,143
2014-11-18 CPXX Buy 10,000 2.20 22,000
2013-12-17 CPXX Buy 3,000 3.50 10,491

Table 2. Insider trading of Macrogenics Inc (MGNX) by Jackson Scott Thomas

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-20 MGNX Option Ex 6,500 .00 0
2024-05-20 MGNX Option Ex 4,500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jackson Scott Thomas (Director of Macrogenics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.